Egg Mitochondria Supplements: PQQ, Resveratrol, NMN

Search for supplements that support egg mitochondria and the results arrive in a predictable order: CoQ10, then a second tier of compounds with far less human evidence behind them — PQQ, resveratrol, NMN and other NAD+ boosters, alpha-lipoic acid, spermidine. The marketing language is almost identical for all of them, which is the problem. The evidence behind them is not identical at all.

We have already written about the supplements with the strongest evidence for egg quality after 40 — CoQ10, melatonin, NAC, vitamin D and mineral repletion — and about the gut-mitochondria connection behind egg quality. This article covers the part of the conversation that usually gets skipped: the newer mitochondrial compounds, the forms and doses that actually reach your cells, what is in the bottle you bought, and the situations in which a mitochondrial supplement is the wrong move.

Do PQQ, resveratrol and NAD+ boosters actually improve egg mitochondria?

In humans, not on current evidence. PQQ, resveratrol, NMN and spermidine all have a plausible mitochondrial mechanism and encouraging results in animal and laboratory work, but the human fertility data is either absent or neutral for the outcomes patients care about — eggs retrieved, embryos, pregnancy and live birth. CoQ10 remains the only mitochondrial-support supplement with repeated randomised human trials in fertility populations. Everything in the second tier should be treated as experimental, chosen for a specific reason, and reviewed with the clinician managing your care.

What do egg mitochondria actually do, and what can a capsule change?

A maturing egg is one of the most energy-hungry cells in the body. Mitochondria supply the ATP that powers chromosome separation, spindle assembly, fertilisation and the first days of embryo division before implantation, and they help set the redox balance inside the cell. That is the real rationale for mitochondrial support, and it is why mitochondrial dysfunction shows up in discussions of egg quality far more often than any single hormone value.

What a capsule can plausibly change is narrow: substrate availability, antioxidant capacity in specific tissues, and some signaling pathways. What it cannot change is the age-related chromosomal risk in the egg, the number of follicles you have, or a metabolic environment that stays unaddressed. If insulin signaling, thyroid function, iron status, sleep or inflammation are driving the problem, a mitochondrial supplement is being asked to compensate for something upstream — which is why we start with changing the environment the egg develops in rather than with a stack.

Does PQQ improve ovarian function in women?

Pyrroloquinoline quinone is sold specifically on the claim that it stimulates mitochondrial biogenesis — the creation of new mitochondria — and cell and animal work does support that mechanism. In a 2026 study in Theriogenology, adding PQQ to the culture medium during in vitro maturation of pig oocytes improved maturation rates and reduced reactive oxygen species at one specific concentration. That is a dish, not a person, and the dose in a culture well has no relationship to a capsule taken by mouth.

The one human ovarian study to date is sobering. Fifty healthy women aged 25 to 42 with regular cycles took 20 mg of PQQ daily for about 90 days in a single-arm, open-label study reported in Frontiers in Endocrinology in 2026. Serum AMH did not change overall. A non-significant rise appeared in an exploratory subgroup of seven younger women with lower baseline AMH, alongside a fall in an oxidative-stress marker — a hypothesis worth testing properly, not a result to build a protocol on. There is no trial of PQQ measuring eggs retrieved, embryo quality, pregnancy or live birth.

Read that honestly: PQQ is currently a mechanism with a marketing budget. If you are taking it, you should be able to say what you expect it to do and how you would know whether it worked.

Is resveratrol worth taking before IVF?

Resveratrol is the clearest example of why "improves mitochondrial activity" is not the same as "improves outcomes." An exploratory randomised placebo-controlled trial published in the Journal of Ovarian Research in 2024 gave 150 mg daily for the three months before ovarian stimulation to women over 35 with good ovarian reserve (AMH above 1.2 ng/mL), with 37 in the resveratrol arm and 33 controls. There were no significant differences in the number of oocytes retrieved, or in biochemical pregnancy, clinical pregnancy or live birth rates. What did improve were two measures of how efficiently the follicles responded to FSH — the follicle output rate and the follicle-to-oocyte index.

That is an interesting signal about ovarian sensitivity to stimulation, from a small exploratory trial, and it is not a reason to promise better embryos. A 2024 systematic review of resveratrol and female fertility in the International Journal of Molecular Sciences reached the same general conclusion: mechanistically attractive, clinically unproven, and complicated by the compound's hormonal and signaling activity.

Timing matters more with resveratrol than with most supplements. It is a polyphenol with oestrogen-related and cell-signaling effects, evidence in pregnancy comes almost entirely from animal models with mixed findings, and most protocols stop it before conception or transfer. Decide the stop date with your reproductive endocrinologist or OB-GYN before you start, not after a positive test.

Do NMN and other NAD+ boosters help egg quality?

NAD+ declines with age, and restoring it in mice restores a surprising amount of oocyte function. A 2026 review in Clinical and Experimental Reproductive Medicine pulled the preclinical evidence together: in animal models NMN improved mitochondrial function, reduced oxidative stress, modulated sirtuin signaling, and improved oocyte quality and reproductive lifespan. Similar work exists for spermidine, which protected mouse and pig oocytes against heat stress and chemical exposures in 2026 studies.

Every sentence in that paragraph describes an animal or a culture dish. There is no randomised human trial showing that NMN, NR or spermidine improves eggs, embryos or births, the long-term safety data in women trying to conceive is thin, and regulatory status varies by country. This is the most oversold category in the egg-quality market right now, and the honest position is that it is a promising research direction rather than a treatment.

Is ubiquinol better than regular CoQ10?

CoQ10 is the one compound in this conversation with repeated human trials. A 2024 systematic review and meta-analysis in Annals of Medicine pooled six randomised trials and 1,529 participants with diminished ovarian reserve undergoing IVF or ICSI and found CoQ10 pretreatment associated with higher clinical pregnancy rates, more oocytes retrieved, fewer cancelled cycles and lower gonadotropin requirements. Earlier meta-analyses across broader ART populations have been less consistent, so the effect looks strongest where mitochondrial reserve is the limiting factor.

Form and absorption are where patients waste money. Ubiquinol is the reduced form and is often better absorbed, but CoQ10 is fat-soluble and notoriously variable between people: a small comparative study in the Journal of Functional Biomaterials found large differences in plasma response between formulations and striking variation between individuals taking the same product. Practical implications: take it with a meal containing fat, split larger daily doses, and judge a product by its formulation rather than its milligram number alone. If you take warfarin or another anticoagulant, or you are on a statin or blood-pressure medication, clear the dose with your prescriber — CoQ10 is one of the more commonly flagged supplement interactions.

The 90 days before a retrieval is the window where CoQ10 is usually deployed, because the follicles recruited for that cycle have been developing for months.

Does alpha-lipoic acid belong in an egg-quality plan?

Alpha-lipoic acid is both water- and fat-soluble, reaches mitochondria, and regenerates other antioxidants, which is why it appears in fertility stacks. The human fertility evidence sits mostly outside egg quality: a 2026 randomised trial in 151 women with PCOS found that adding ALA to letrozole improved ovulation-induction outcomes, a 2025 meta-analysis found benefits for sperm parameters, and a 2026 randomised trial in couples with recurrent pregnancy loss looked at sperm DNA fragmentation. Useful signals for ovulation and for the male side — which is half of every embryo, and the reason the male supplement plan needs its own evidence review — but not evidence that ALA improves oocyte mitochondria.

ALA also has a genuine safety tail that supplement marketing never mentions: it is a sulfhydryl compound and one of the more frequently implicated triggers of insulin autoimmune syndrome, a rare cause of hypoglycaemia reviewed in Metabolism Open in 2026. If you have unexplained hypoglycaemic episodes, that belongs in the conversation.

Can taking too many antioxidants backfire?

Yes, at least in principle, and this is the part of the "more is better" logic that deserves to be retired. Reactive oxygen species are not only damage signals — they are part of normal reproductive function. Reviews of ovulation published in 2025 describe the pre-ovulatory LH surge as triggering a local inflammatory and redox cascade, with estradiol-driven mitochondrial ROS helping to drive cumulus expansion, matrix breakdown and follicle rupture. Blanket high-dose antioxidant suppression is not obviously helpful to a process that uses oxidation as a signal.

The practical reading is not "avoid antioxidants." It is that dose, timing and reason matter, that stacking six overlapping antioxidants is not six times the benefit, and that the question to answer first is why oxidative stress is elevated in your case — blood sugar, inflammation, thyroid, gut, sleep, environmental exposure, or the glucose and insulin pattern behind your day. Fix the driver and the antioxidant requirement usually falls.

How do you know what is actually in the bottle?

Supplement quality is not a side issue in this category, because most of these compounds are fragile or poorly regulated. Two published examples make the point. When researchers analysed 31 commercial melatonin products for the Journal of Clinical Sleep Medicine in 2017, measured content ranged from 83% below to 478% above the label, more than 71% missed the label claim by more than 10%, lot-to-lot variation within a product reached 465%, and serotonin was detected in eight products. And in a 2015 analysis of 171 North American omega-3 supplements in the Journal of Nutritional Science, half exceeded voluntary limits for markers of oxidation — meaning the oil was already rancid before it reached the patient, a concern reviewed in BioMed Research International in 2013.

What to do with that: buy products with third-party verification, check expiry dates and store fish oil cold, discard any omega-3 that smells or tastes rancid, avoid proprietary blends that hide per-ingredient doses, and keep a single written list of everything you take with doses. That list is one of the most useful documents you can bring to a fertility consultation, and one of the rarest. Most patients arrive with a photo of a shelf.

What should you stop, and when?

This is the question almost no supplement page answers, and it needs your medical team's input rather than a blog's: hormonal precursors such as DHEA behave differently from antioxidants and can worsen acne, hair growth and mood, particularly where androgens are already elevated; anticoagulant users need dose review for CoQ10 and high-dose omega-3; polyphenols such as resveratrol are usually stopped before transfer or conception; and anything not prescribed should be on the list you hand your reproductive endocrinologist before a retrieval. We are an acupuncture and functional-medicine clinic — we do not prescribe or order labs, and prescriptive supplement decisions belong with your RE or OB-GYN.

Supplements are also not the only lever on mitochondrial function — the blood-flow and signaling side of mitochondrial support is worth understanding before you add another capsule. A reasonable default in an IVF or IUI support plan is a solid prenatal foundation, one or two additions chosen for reasons you can state, a defined review date, and a stop plan for each item. Not a shelf.

How we decide what goes in the plan

At our Huntington clinic, mitochondrial support is one output of an evaluation, never the starting point. A Metabolic & Immune Fertility Evaluation looks at lab trends rather than single results, insulin and metabolic markers, thyroid and immune patterns, iron and nutrient status, cycle symptoms and confirmed ovulation, prior stimulation and embryo results, and advanced sperm testing — and then builds a Personalized 90-Day Fertility Roadmap around the three dials we can influence: Blood Flow & Signaling, Egg & Sperm Quality, and the Fertility Environment.

Patients across Long Island arrive with four to nine supplements, no baseline labs for most of them, and no review date. More often than not the plan gets shorter and the results get better, because the changes that matter move upstream — glucose and insulin, inflammation, thyroid, iron, sleep, ovarian blood flow — and because the reasons behind low egg reserve or a stalled embryo cohort are rarely a missing antioxidant. If you want that assessment rather than another stack, a free 10-minute call is the simplest place to start.

This article is for educational purposes only and is not medical advice. It does not replace care from your OB-GYN or reproductive endocrinologist. Always discuss testing, supplements and treatment decisions with your own medical team.

East to West Fertility is a metabolic and immune-focused fertility clinic in Huntington, Long Island, serving patients across Long Island, NYC, and beyond. Learn more about our Metabolic & Immune Fertility Evaluation or call 631-416-4940.

References:

• Tsuji S, Takiuchi T, Handa M, et al. "Serum anti-Müllerian hormone response to pyrroloquinoline quinone supplementation in healthy women: no overall change and exploratory subgroup findings." Frontiers in Endocrinology, 2026;17:1831604. (Single-arm, open-label; 50 women aged 25-42, 20 mg/day for 90 ± 10 days; per-protocol n = 35.)
• Zhai D, Diao Y, Wu Y, et al. "Pyrroloquinoline quinone enhances in vitro maturation of porcine oocytes and supports ensuing embryonic development." Theriogenology, 2026;261:117935. (In vitro maturation, 0-10 μM PQQ.)
• Conforti A, Iorio GG, Di Girolamo R, et al. "The impact of resveratrol on the outcome of the in vitro fertilization: an exploratory randomized placebo-controlled trial." Journal of Ovarian Research, 2024;17(1):81. (150 mg/day for 3 months; 37 cases, 33 controls.)
• Bertoldo A, Pizzol D, Yon DK, et al. "Resveratrol and female fertility: a systematic review." International Journal of Molecular Sciences, 2024;25(23):12792.
• Kang I, Lee J. "The impact of nicotinamide mononucleotide on ovarian health: a comprehensive literature review of preclinical evidence and therapeutic potential." Clinical and Experimental Reproductive Medicine, 2026.
• Chen M, Sun X, Yan J, Sun S, Xiong B. "Spermidine alleviates heat stress-induced deterioration of porcine oocytes." Theriogenology, 2026;254:117810.
• Lin G, Li X, Jin Yie SL, Xu L. "Clinical evidence of coenzyme Q10 pretreatment for women with diminished ovarian reserve undergoing IVF/ICSI: a systematic review and meta-analysis." Annals of Medicine, 2024;56(1):2389469. (6 RCTs, 1,529 participants.)
• Florou P, Anagnostis P, Theocharis P, Chourdakis M, Goulis DG. "Does coenzyme Q10 supplementation improve fertility outcomes in women undergoing assisted reproductive technology procedures? A systematic review and meta-analysis of randomized-controlled trials." Journal of Assisted Reproduction and Genetics, 2020;37(10):2377-2387.
• Vitetta L, Leong A, Zhou J, Dal Forno S, Hall S, Rutolo D. "The plasma bioavailability of coenzyme Q10 absorbed from the gut and the oral mucosa." Journal of Functional Biomaterials, 2018;9(4):73.
• Sallam MA, Hamza H, Shaheen SM, Ahmed MA. "Effect of alpha-lipoic acid supplementation on polycystic ovary syndrome clinical outcome in infertile females treated with letrozole: a randomized controlled trial." Saudi Pharmaceutical Journal, 2026;34(4):54. (151 women with PCOS.)
• Pires IZ, Gobbo MODS, Sudo RYU, et al. "Efficacy of alpha lipoic acid supplementation in sperm parameters: a systematic review and meta-analysis of randomized trials." International Brazilian Journal of Urology, 2025;51(4):e20240614.
• Vallianou NG, Kounatidis DC, Dalamaga M, et al. "Alpha-lipoic acid as a trigger of insulin autoimmune syndrome: current evidence, a case-based approach, diagnostic pitfalls, and practical management." Metabolism Open, 2026;31:100491.
• Varga D, Szatmári P, Ducza E. "Inflammatory and redox mediators in rat and human ovulation." International Journal of Molecular Sciences, 2025;26(24):11979.
• Chen YH, Chu TY. "Ovulation: a consequence of acute inflammation cultivated by E2-induced reactive oxygen species and triggered by progesterone withdrawal." Tzu Chi Medical Journal, 2025;37(4):351-359.
• Erland LA, Saxena PK. "Melatonin natural health products and supplements: presence of serotonin and significant variability of melatonin content." Journal of Clinical Sleep Medicine, 2017;13(2):275-281. (31 products analysed.)
• Jackowski SA, Alvi AZ, Mirajkar A, et al. "Oxidation levels of North American over-the-counter n-3 (omega-3) supplements and the influence of supplement formulation and delivery form on evaluating oxidative safety." Journal of Nutritional Science, 2015;4:e30. (171 supplements.)
• Albert BB, Cameron-Smith D, Hofman PL, Cutfield WS. "Oxidation of marine omega-3 supplements and human health." BioMed Research International, 2013;2013:464921.
• Xu L, Hu C, Liu Q, Li Y. "The effect of dehydroepiandrosterone (DHEA) supplementation on IVF or ICSI: a meta-analysis of randomized controlled trials." Geburtshilfe und Frauenheilkunde, 2019;79(7):705-712. (9 RCTs, 833 patients.)
• Wu Y, Huang W, Tang L, et al. "Melatonin improved the outcomes of women with ART: a systematic review and meta-analysis of randomized trials." Frontiers in Reproductive Health, 2025;7:1680984. (11 RCTs, 1,481 participants.)